Kora Saúde Participações Past Earnings Performance
Past criteria checks 0/6
Kora Saúde Participações's earnings have been declining at an average annual rate of -65.9%, while the Healthcare industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 33% per year.
Key information
-65.9%
Earnings growth rate
-72.1%
EPS growth rate
| Healthcare Industry Growth | 11.6% |
| Revenue growth rate | 33.0% |
| Return on equity | -12.8% |
| Net Margin | -6.4% |
| Next Earnings Update | 14 Aug 2024 |
Recent past performance updates
Recent updates
Why Investors Shouldn't Be Surprised By Kora Saúde Participações S.A.'s (BVMF:KRSA3) 26% Share Price Plunge
Apr 16
Little Excitement Around Kora Saúde Participações S.A.'s (BVMF:KRSA3) Revenues As Shares Take 25% Pounding
Feb 06There Are Reasons To Feel Uneasy About Kora Saúde Participações' (BVMF:KRSA3) Returns On Capital
Jan 17Kora Saúde Participações S.A. (BVMF:KRSA3) Stock Catapults 27% Though Its Price And Business Still Lag The Industry
Dec 05Should You Investigate Kora Saúde Participações S.A. (BVMF:KRSA3) At R$1.17?
Sep 07Kora Saúde Participações' (BVMF:KRSA3) Returns On Capital Not Reflecting Well On The Business
Jul 24Returns On Capital Signal Tricky Times Ahead For Kora Saúde Participações (BVMF:KRSA3)
Jan 10Kora Saúde Participações S.A. (BVMF:KRSA3) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Apr 04Revenue & Expenses Breakdown
How Kora Saúde Participações makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 2,272 | -145 | 165 | 0 |
| 31 Dec 23 | 2,260 | -168 | 193 | 0 |
| 30 Sep 23 | 2,233 | -212 | 211 | 0 |
| 30 Jun 23 | 2,167 | -222 | 238 | 0 |
| 31 Mar 23 | 2,121 | -172 | 227 | 0 |
| 31 Dec 22 | 2,047 | -108 | 225 | 0 |
| 30 Sep 22 | 1,923 | -122 | 254 | 0 |
| 30 Jun 22 | 1,736 | -83 | 231 | 0 |
| 31 Mar 22 | 1,524 | -62 | 181 | 0 |
| 31 Dec 21 | 1,262 | -64 | 175 | 0 |
| 30 Sep 21 | 1,029 | 14 | 118 | 0 |
| 30 Jun 21 | 860 | 41 | 95 | 0 |
| 31 Mar 21 | 689 | 28 | 83 | 0 |
| 31 Dec 20 | 612 | 16 | 83 | 0 |
| 31 Dec 19 | 442 | -3 | 67 | 0 |
| 31 Dec 18 | 283 | 1 | 136 | 0 |
| 31 Dec 17 | 264 | 6 | 118 | 0 |
Quality Earnings: KRSA3 is currently unprofitable.
Growing Profit Margin: KRSA3 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: KRSA3 is unprofitable, and losses have increased over the past 5 years at a rate of 65.9% per year.
Accelerating Growth: Unable to compare KRSA3's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: KRSA3 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (63.3%).
Return on Equity
High ROE: KRSA3 has a negative Return on Equity (-12.75%), as it is currently unprofitable.